Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 03, 2013 18:05 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Reports Full Year and Fourth Quarter 2012 Financial Results

EDMONTON, Alberta, April 3, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) (the "Company") has released its financial results for the year and quarter ended December 31, 2012. Recent...
February 05, 2013 12:30 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Merger With Aurinia to Create Leading Nephrology Company

EDMONTON, Alberta, Feb. 5, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") and privately-held Aurinia Pharmaceuticals Inc. ("Aurinia") announced today the...
January 15, 2013 16:15 ET | Source: Aurinia Pharmaceuticals Inc.

ILJIN Withdraws Damages Claims Against Isotechnika

EDMONTON, Alberta, Jan. 15, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") is pleased to announce that ILJIN Life Sciences Co. Ltd. ("ILJIN") has formally...
December 27, 2012 07:50 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Announces That Lux Biosciences' Phase 3 Uveitis Study Did Not Meet Primary Endpoint

EDMONTON, Alberta, Dec. 27, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") announced today that the Phase 3 clinical study using voclosporin for the...
December 06, 2012 15:00 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Pharma's NICAM Compounds Demonstrate Positive Anti-Hepatitis C Virus Activity in Secondary Level Testing at NIH-Funded Labs

EDMONTON, Alberta, Dec. 6, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") is pleased to announce positive anti-hepatitis C virus ("HCV") results from the...
November 30, 2012 08:00 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Receives Partial Award in ICC Arbitration With ILJIN

EDMONTON, Alberta, Nov. 30, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") announced today that, further to its press release of November 14, 2012, a...
November 26, 2012 08:00 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Cleared by FDA to Commence Phase 3 Voclosporin Trial

EDMONTON, Alberta, Nov. 26, 2012 (GLOBE NEWSWIRE) -- Isotechnika Inc. (TSX:ISA) ("Isotechnika" or the "Company") announced today that it has received permission from the U.S. Food and Drug...
November 14, 2012 08:00 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Reports Third Quarter 2012 Financial Results

EDMONTON, Alberta, Nov. 14, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) today announced financial results for the third quarter ended September 30, 2012. The Company's financial and...
November 06, 2012 07:35 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Pharma's NICAM Portfolio Demonstrates Positive Anti-Viral Activity Against Several Important Viruses

EDMONTON, Alberta, Nov. 6, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") is pleased to announce positive results from the first round of screening of its...
October 31, 2012 08:00 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Pharma Announces Close of Second Tranche of Private Placement of Units

EDMONTON, Alberta, Oct. 31, 2012 (GLOBE NEWSWIRE) -- Further to its press release of October 16, 2012, Isotechnika Pharma Inc. (TSX:ISA) announced today that it has completed the second tranche of its...